Robert Baffi - Net Worth and Insider Trading

Robert Baffi Net Worth

The estimated net worth of Robert Baffi is at least $13 Million dollars as of 2024-03-19. Robert Baffi is the EVP, Technical Operations of Biomarin Pharmaceutical Inc and owns about 155,158 shares of Biomarin Pharmaceutical Inc (BMRN) stock worth over $13 Million. Details can be seen in Robert Baffi's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert Baffi has not made any transactions after 2018-08-07 and currently still holds the listed stock(s).

Transaction Summary of Robert Baffi

To

Robert Baffi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Baffi owns 3 companies in total, including Biomarin Pharmaceutical Inc () , Humanigen Inc () , and Mosaic ImmunoEngineering Inc () .

Click here to see the complete history of Robert Baffi’s form 4 insider trades.

Insider Ownership Summary of Robert Baffi

Ticker Comapny Transaction Date Type of Owner
Biomarin Pharmaceutical Inc 2018-08-07 SVP & Technical Operations
Humanigen Inc 2014-11-25 director
Mosaic ImmunoEngineering Inc 2021-07-15 director

Robert Baffi Latest Holdings Summary

Robert Baffi currently owns a total of 1 stock. Robert Baffi owns 155,158 shares of Biomarin Pharmaceutical Inc (BMRN) as of August 7, 2018, with a value of $13 Million.

Latest Holdings of Robert Baffi

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BMRN Biomarin Pharmaceutical Inc 2018-08-07 155,158 83.81 13,003,792

Holding Weightings of Robert Baffi


Robert Baffi Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert Baffi has made a total of 0 transactions in Biomarin Pharmaceutical Inc (BMRN) over the past 5 years. The most-recent trade in Biomarin Pharmaceutical Inc is the sale of 5,173 shares on August 7, 2018, which brought Robert Baffi around $543,165.

Insider Trading History of Robert Baffi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert Baffi Trading Performance

GuruFocus tracks the stock performance after each of Robert Baffi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert Baffi is -21.01%. GuruFocus also compares Robert Baffi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert Baffi within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert Baffi's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert Baffi

Average Relative Return

4.4%

Average relative return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 0.49 -21.01 -35.83 4.4 47.29 40.12
Relative Return to S&P 500(%) -4.05 -20.27 -42.8 -2.88 36.98 29

Robert Baffi Ownership Network

Ownership Network List of Robert Baffi

No Data

Ownership Network Relation of Robert Baffi


Robert Baffi Owned Company Details

What does Biomarin Pharmaceutical Inc do?

Who are the key executives at Biomarin Pharmaceutical Inc?

Robert Baffi is the SVP & Technical Operations of Biomarin Pharmaceutical Inc. Other key executives at Biomarin Pharmaceutical Inc include director & Chief Executive Officer Jean Jacques Bienaime , EVP & Chief Commercial Officer Jeffrey Robert Ajer , and Chief Medical Officer Henry J Fuchs .

Biomarin Pharmaceutical Inc () Insider Trades Summary

Over the past 18 months, Robert Baffi made no insider transaction in Biomarin Pharmaceutical Inc (). Other recent insider transactions involving Biomarin Pharmaceutical Inc () include a net sale of 255,000 shares made by Jean Jacques Bienaime , a net sale of 61,000 shares made by Jeffrey Robert Ajer , and a net sale of 17,380 shares made by Brian Mueller .

In summary, during the past 3 months, insiders sold 102,341 shares of Biomarin Pharmaceutical Inc () in total and bought 0 shares, with a net sale of 102,341 shares. During the past 18 months, 419,345 shares of Biomarin Pharmaceutical Inc () were sold and 3,625 shares were bought by its insiders, resulting in a net sale of 415,720 shares.

Biomarin Pharmaceutical Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Biomarin Pharmaceutical Inc Insider Transactions

No Available Data

Robert Baffi Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Baffi. You might contact Robert Baffi via mailing address: C/o Biomarin Pharmaceutical Inc., 105 Digital Drive, Novato Ca 94949.

Discussions on Robert Baffi

No discussions yet.